Research
Innovative Imaging
Making the invisible visible for better care
Before a patient can be treated, they must first be understood and that starts with an accurate, detailed diagnosis. At HTRIC, we are advancing imaging technologies that give clinicians a clearer view inside the body, helping them pinpoint disease earlier and treat it more precisely.
Using advanced tools like PET and MRI, paired with special tracers that “light up” disease activity at the molecular level, clinicians can:
- Detect tumors or abnormalities before structural changes appear
- Track disease progression with high precision
- Target treatments more effectively while minimizing side effects
Groningen is a recognized global leader in the field of molecular imaging and medical tracers. Research groups at the University Medical Center Groningen (UMCG) are working alongside pioneering companies like SHINE and TRACER to push boundaries in:
- Radiopharmaceutical development
- Imaging-guided therapies
- Real-time diagnostic monitoring
Imagine a cancer treatment that is guided by a scan showing exactly where tumor cells are active or a drug that can be tracked inside the body to see if it’s reaching the right target. These innovations are already happening, and HTRIC is helping bring them to the clinic faster.
We believe that when doctors can see disease more clearly, they can treat it more accurately and patients get better outcomes.
- Ecosystem partners: Zernike Institute, W.J. Kolff, PolyVation, Polyganics
- Future opportunity: Nanogel coatings with a wide range of applications
- Technology: Biomaterials, Coatings
